Vanguard Global Advisers’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.71M Sell
166,490
-1,604
-1% -$27.7K ﹤0.01% 1058
2026
Q2
$3.02M Sell
168,094
-20,327
-11% -$284K ﹤0.01% 1011
2026
Q1
$1.77M Buy
+188,421
New +$2.07M ﹤0.01% 1271

Other funds holding IART

Vanguard Global Advisers's IART Position: Q3 2026 in Review

Vanguard Global Advisers reduced its Integra LifeSciences (IART) stake by 0.95% in Q3 2026, selling an estimated $27.7K and leaving 166,490 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1058.

Vanguard Global Advisers first reported a position in IART in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.02M in Q2 2026. 234 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Vanguard Global Advisers held 166,490 shares of Integra LifeSciences worth $2.71M as of Q3 2026.
  • Vanguard Global Advisers sold 1,604 Integra LifeSciences shares in Q3 2026, an estimated $27.7K.
  • Integra LifeSciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1058 holding.
  • Vanguard Global Advisers first reported a position in Integra LifeSciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Integra LifeSciences position peaked at $3.02M in Q2 2026.
  • 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.